Methamphetamine-Triggered Neurotoxicity in Human Dorsolateral Prefrontal Cortex
DOI:
https://doi.org/10.31661/gmj.v10i.2016Keywords:
Methamphetamine; Prefrontal Cortex; Apoptosis; BDNFAbstract
Background: Methamphetamine (MA), is an extremely addictive stimulant that adversely affects the central nervous system. Accumulating evidence indicates that molecular mechanisms such as oxidative stress, apoptosis, and autophagy are involved in the toxicity of MA. Considering experimental animal studies exhibiting MA-induced neurotoxicity, the relevance of these findings needs to be evidently elucidated in human MA users. It is generally assumed that multiple chemical substances released in the brain following MA-induced metabolic activation are primary factors underlying damage of neural cells. Hence, this study aimed to investigate the role of autophagy and apoptosis as well as oxidative stress in the brain of postmortem MA-induced toxicity. Materials and Methods: In this study, we determine the gene expression of autophagy and apoptosis, including BECN1, MAP1ALC3, CASP8, TP53, and BAX genes in ten healthy controls and ten chronic users of MA postmortem dorsolateral prefrontal cortex (DLPFC) by real-time polymerase chain reaction. Also, we applied immunohistochemistry in formalin-fixed and paraffin-embedded human brain samples to analyze brain-derived neurotrophic factor (BDNF). Also, spectrophotometry was performed to measure glutathione (GSH) content. Results: The expression level of apoptotic and autophagic genes (BECN1, MAP1ALC3, CASP8, TP53, and BAX) were significantly elevated, while GSH content and BDNF showed substantial reductions in DLPFC of chronic MA users. Conclusion: Our data showed that MA addiction provokes transduction pathways, namely apoptosis and autophagy, along with oxidative mechanisms in DLPFC. Also, MA induces multiple functional and structural perturbations in the brain, determining its toxicity and possibly contributing to neurotoxicity. [GMJ.2021;10:e2016]
References
Rommel N, Rohleder NH, Wagenpfeil S, Härtel-Petri R, Jacob F, Wolff K-D, et al. The impact of the new scene drug "crystal meth" on oral health: a case-control study. Clin Oral Investig. 2016;20(3):469-75. https://doi.org/10.1007/s00784-015-1527-zPMID: 26174081 Kish SJ. Pharmacologic mechanisms of crystal meth. Can Med Assoc J. 2008;178(13):1679-82. https://doi.org/10.1503/cmaj.071675PMID: 18559805 PMCID: PMC2413312 Volkow ND, Fowler JS, Wang G-J, Shumay E, Telang F, Thanos PK, et al. Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. PLoS One. 2010;5(12):e15269. https://doi.org/10.1371/journal.pone.0015269PMID: 21151866 PMCID: PMC2998419 Schep LJ, Slaughter RJ, Beasley DMG. The clinical toxicology of metamfetamine. Clin Toxicol. 2010;48(7):675-94. https://doi.org/10.3109/15563650.2010.516752PMID: 20849327 Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology. 2014;39(5):1066. https://doi.org/10.1038/npp.2013.307PMID: 24169803 PMCID: PMC3957101 Morrow BA, Roth RH, Redmond DE, Elsworth JD. Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease. Neuroscience. 2011;189:277-85. https://doi.org/10.1016/j.neuroscience.2011.05.046PMID: 21640165 PMCID: PMC3150352 Rose ME, Grant JE. Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry. 2008;20(3):145-55. https://doi.org/10.1080/10401230802177656PMID: 18633741 Möbius C, Kustermann A, Struffert T, Kornhuber J, Müller HH. c-MRI findings after crystal meth abuse. J Addict Med. 2014;8(5):384-5. https://doi.org/10.1097/ADM.0000000000000051PMID: 25026102 Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend. 2012;120(1-3):35-40. https://doi.org/10.1016/j.drugalcdep.2011.06.013PMID: 21794992 Hoshi E. Functional specialization within the dorsolateral prefrontal cortex: a review of anatomical and physiological studies of non-human primates. Neurosci Res. 2006;54(2):73-84. https://doi.org/10.1016/j.neures.2005.10.013PMID: 16310877 Klaus J, Schutter DJ. The Role of Left Dorsolateral Prefrontal Cortex in Language Processing. Neuroscience. 2018;377:197-205. https://doi.org/10.1016/j.neuroscience.2018.03.002PMID: 29534975 Yamamoto DJ, Woo C-W, Wager TD, Regner MF, Tanabe J. Influence of dorsolateral prefrontal cortex and ventral striatum on risk avoidance in addiction: a mediation analysis. Drug Alcohol Depend. 2015;149:10-7. https://doi.org/10.1016/j.drugalcdep.2014.12.026PMID: 25736619 PMCID: PMC4361089 Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nature reviews neuroscience. 2011;12(11):652. https://doi.org/10.1038/nrn3119PMID: 22011681 PMCID: PMC3462342 Yu S, Zhu L, Shen Q, Bai X, Di X. Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol. 2015; 2015. https://doi.org/10.1155/2015/103969PMID: 25861156 PMCID: PMC4377385 Roohbakhsh A, Shirani K, Karimi G. Methamphetamine-induced toxicity: The role of autophagy? Chem Biol Interact. 2016;260:163-7. https://doi.org/10.1016/j.cbi.2016.10.012PMID: 27746146 Wu A, Ying Z, Gomezâ€Pinilla F. The interplay between oxidative stress and brainâ€derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci. 2004;19(7):1699-707. https://doi.org/10.1111/j.1460-9568.2004.03246.xPMID: 15078544 Halpin LE, Collins SA, Yamamoto BK. Neurotoxicity of methamphetamine and 3, 4-methylenedioxymethamphetamine. Life Sci. 2014;97(1): 37-44. https://doi.org/10.1016/j.lfs.2013.07.014PMID: 23892199 PMCID: PMC3870191 Volkow N, Fowler J, Wang G, Baler R, Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;56:3-8. https://doi.org/10.1016/j.neuropharm.2008.05.022PMID: 18617195 PMCID: PMC2696819 Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, et al. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry. 2003;160(9):1699-701. https://doi.org/10.1176/appi.ajp.160.9.1699PMID: 12944350 Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci. 2002;22(20):8951-60. https://doi.org/10.1523/JNEUROSCI.22-20-08951.2002PMID: 12388602 PMCID: PMC6757693 Fornai F, Lenzi P, Gesi M, Soldani P, Ferrucci M, Lazzeri G, et al. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J Neurochem. 2004;88(1):114-23. https://doi.org/10.1046/j.1471-4159.2003.02137.xPMID: 14675155 Kanthasamy A, Anantharam V, Ali SF, Kanthasamy A. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsinâ€D in methamphetamineâ€induced apoptotic cell death. Annals of the New York Academy of Sciences. 2006;1074(1):234-44. https://doi.org/10.1196/annals.1369.022PMID: 17105920 Quan L, Ishikawa T, Michiue T, Li D-R, Zhao D, Oritani S, et al. Ubiquitin-immunoreactive structures in the midbrain of methamphetamine abusers. Leg Med. 2005;7(3):144-50. https://doi.org/10.1016/j.legalmed.2004.11.002PMID: 15847821 Cadet JL, Jayanthi S, Deng X. Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review. Neurotox Res. 2005;8(3-4):199-206. https://doi.org/10.1007/BF03033973PMID: 16371314 Asanuma M, Miyazaki I, Higashi Y, Diaz-Corrales FJ, Shimizu M, Miyoshi K, et al. Suppression of p53-activated gene, PAG608, attenuates methamphetamine-induced neurotoxicity. Neurosci Lett. 2007;414(3):263-7. https://doi.org/10.1016/j.neulet.2006.12.036PMID: 17234339 KowiaÅ„ski P, Lietzau G, Czuba E, WaÅ›kow M, Steliga A, MoryÅ› J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol. 2018; 38(3):579-93. https://doi.org/10.1007/s10571-017-0510-4PMID: 28623429 PMCID: PMC5835061 Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Archives of medical science: AMS. 2015;11(6):1164. https://doi.org/10.5114/aoms.2015.56342PMID: 26788077 Weickert C, Hyde T, Lipska B, Herman M, Weinberger D, Kleinman J. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003;8(6):592. https://doi.org/10.1038/sj.mp.4001308PMID: 12851636 Reinhart V, Bove SE, Volfson D, Lewis DA, Kleiman RJ, Lanz TA. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder. Neurobiol Dis. 2015;77:220-7. https://doi.org/10.1016/j.nbd.2015.03.011PMID: 25796564 Jang EY, Yang CH, Hedges DM, Kim SP, Lee JY, Ekins TG, et al. The role of reactive oxygen species in methamphetamine selfâ€administration and dopamine release in the nucleus accumbens. Addict Biol. 2017;22(5):1304-15. https://doi.org/10.1111/adb.12419PMID: 27417190 PMCID: PMC5237425 Cadet JL, Krasnova IN. Molecular bases of methamphetamine-induced neurodegeneration. Int Rev Neurobiol. 2009;88:101-19. https://doi.org/10.1016/S0074-7742(09)88005-7PMID: 19897076 PMCID: PMC8247532 Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol. 2009;88:43-64. https://doi.org/10.1016/S0074-7742(09)88003-3PMID: 19897074 Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP. Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium. Neurotoxicology. 2013;37:240-6. https://doi.org/10.1016/j.neuro.2013.05.009PMID: 23721877 PMCID: PMC3717519 Limanaqi F, Gambardella S, Biagioni F, Busceti CL, Fornai F. Epigenetic Effects Induced by Methamphetamine and Methamphetamine-Dependent Oxidative Stress. Oxid Med Cell Longev. 2018;2018:4982453. https://doi.org/10.1155/2018/4982453PMID: 30140365 PMCID: PMC6081569 Eskandarian Boroujeni M, Peirouvi T, Shaerzadeh F, Ahmadiani A, Abdollahifar MA, Aliaghaei A. Differential gene expression and stereological analyses of the cerebellum following methamphetamine exposure. Addict Biol. 2020 ;25(1):e12707. https://doi.org/10.1111/adb.12707PMID: 30714656
